Genentech, a member of the Roche Group, has appointed Bill Anderson to chief executive officer, effective January 1, 2017.

Mr. Anderson, who is also the head of North American commercial operations, has served in a number of leadership positions at Genentech and Roche over the past 10 years, most recently as head of global product strategy.

Mr. Anderson succeeds Ian T. Clark, who will retire at the end of 2016 after 14 years at Genentech. Following the 2009 merger with Roche, Mr. Clark drove the evolution of Genentech as part of a global organization and has overseen the launch of 15 new medicines.

Source: Genentech